Peng Li, PhD Merck & Co

Peng Li, Ph.D. is currently a Device Program Lead/Principal Scientist in the Device Development group of Merck & Co., Inc. leading the development of various injectable combination products across disease areas and drug modalities. Peng has over 12 years of experience in new product development and project management in the pharmaceutical, medical device, and life sciences industries. Prior to joining Merck, Peng was with Becton Dickinson where he was the R&D lead of the BD Libertas™ Wearable Injector. Peng also worked at Thermo Fisher Scientific where he was a key designer of the SeqStudio™ Genetic Analyzer.